Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 984 entries
View as:

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Phase: N/A Priority: Normal
NCT ID: NCT04313244 Org: User:
Start: 05/15/21 End: 07/19/22 Due: 07/19/23

Study to Assess Absolute Bioavailability of TAK-935 (OV935) and to Characterize Mass Balance, Pharmacokinetics, Metabolism, and Excretion of [14C]TAK-935 (OV935) in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04992442 Org: User:
Start: 07/09/20 End: 08/18/20 Due: 08/18/21

A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT04654351 Org: User:
Start: 01/15/21 End: 07/27/21 Due: 07/27/22

Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT02379091 Org: User:
Start: 12/17/14 End: 12/05/16 Due: 12/05/17

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT00847210 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01497288 Org: User:
Start: 11/30/11 End: 12/31/11 Due: 12/31/12

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01452698 Org: User:
Start: - End: 08/31/12 Due: 08/31/13

A Study About Fazirsiran in People With and Without Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT05891158 Org: User:
Start: 10/05/23 End: 09/15/25 Due: 09/15/26

TAK-438 Bismuth Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT02892409 Org: User:
Start: 09/05/16 End: 05/11/17 Due: 05/11/18

A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

Phase: N/A Priority: Normal
NCT ID: NCT02369796 Org: User:
Start: 02/28/15 End: 11/30/15 Due: 11/30/16

NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"

Phase: N/A Priority: Normal
NCT ID: NCT03169361 Org: User:
Start: 05/24/17 End: 03/08/22 Due: 03/08/23

Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT00377598 Org: User:
Start: 10/31/06 End: 02/29/08 Due: 02/28/09

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Phase: N/A Priority: Normal
NCT ID: NCT00776074 Org: User:
Start: 06/30/06 End: 07/31/07 Due: 07/31/08

Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters

Phase: N/A Priority: Normal
NCT ID: NCT02153073 Org: User:
Start: 05/29/13 End: 05/31/17 Due: 05/31/18

Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT02873702 Org: User:
Start: 12/21/16 End: 11/06/17 Due: 11/06/18

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06045754 Org: User:
Start: 04/18/24 End: 06/28/27 Due: 06/28/28

A Study of TAK-279 in Adults With or Without Kidney Problems

Phase: N/A Priority: Normal
NCT ID: NCT05992155 Org: User:
Start: 09/27/23 End: 05/28/24 Due: 05/28/25

A Study of People With CD30 Positive Lymphoma in China

Phase: N/A Priority: Normal
NCT ID: NCT05506774 Org: User:
Start: 02/28/23 End: 07/03/24 Due: 07/03/25

OTIS Vedolizumab Pregnancy Exposure Registry

Phase: N/A Priority: Normal
NCT ID: NCT02678052 Org: User:
Start: 12/01/15 End: 07/31/22 Due: 07/31/23

A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06268301 Org: User:
Start: 02/06/23 End: 02/20/23 Due: 02/20/24

A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT06555432 Org: User:
Start: 11/14/24 End: 10/01/28 Due: 10/01/29

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05013190 Org: User:
Start: 10/29/21 End: 06/30/27 Due: 06/30/28

Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00249899 Org: User:
Start: 11/30/05 End: 03/31/07 Due: 03/31/08

Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00492232 Org: User:
Start: 04/30/07 End: 05/31/08 Due: 05/31/09

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Phase: N/A Priority: Normal
NCT ID: NCT01931566 Org: User:
Start: 08/01/13 End: 09/06/18 Due: 09/06/19